NCT03681483 2024-07-10RO5126766 for Patients With Advanced KRAS-Mutant Lung CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed15 enrolled
NCT00773526 2016-11-02A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.Hoffmann-La RochePhase 1 Completed52 enrolled